Walleye Capital
FLGT icon

Walleye Capital’s Fulgent Genetics FLGT Stock Holding History

Walleye Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$6.78K – 4734
2025
Q3 		$6.78K Buy
+300
New +$6.18K ﹤0.01% 4299
2025
Q2 		– Sell
-7,800
Closed -$132K – 4655
2025
Q1 		$132K Sell
7,800
-7,600
-49% -$129K ﹤0.01% 3490
2024
Q4 		$284K Buy
15,400
+7,400
+93% +$144K ﹤0.01% 3467
2024
Q3 		$174K Sell
8,000
-14,100
-64% -$315K ﹤0.01% 4097
2024
Q2 		$434K Buy
22,100
+15,200
+220% +$317K ﹤0.01% 3631
2024
Q1 		$150K Buy
6,900
+4,900
+245% +$122K ﹤0.01% 4158
2023
Q4 		$57.8K Buy
+2,000
New +$53.5K ﹤0.01% 4256
2023
Q3 		– Sell
-4,300
Closed -$159K – 5011
2023
Q2 		$159K Hold
4,300
– – ﹤0.01% 3219
2023
Q1 		$134K Buy
+4,300
New +$138K ﹤0.01% 2757
2022
Q4 		– Sell
-100
Closed -$4K – 3325
2022
Q3 		$4K Buy
+100
New +$5.01K ﹤0.01% 2961

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's FLGT Position: Q4 2025 in Review

Walleye Capital sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 64,800 shares — an estimated $1.46M sold.

Walleye Capital first reported a position in FLGT in Q3 2022 and held it in 9 quarters. The position peaked at $1.46M in Q3 2025. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Walleye Capital reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 64,800 Fulgent Genetics shares in Q4 2025, an estimated $1.46M.
  • Walleye Capital first reported a position in Fulgent Genetics in Q3 2022 and held it in 9 quarters.
  • Walleye Capital's Fulgent Genetics position peaked at $1.46M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.